Published in Neurotherapeutics on April 01, 2016
Dose translation from animal to human studies revisited. FASEB J (2007) 15.67
Can animal models of disease reliably inform human studies? PLoS Med (2010) 6.27
Changes in case fatality of aneurysmal subarachnoid haemorrhage over time, according to age, sex, and region: a meta-analysis. Lancet Neurol (2009) 3.66
Calcium antagonists for aneurysmal subarachnoid haemorrhage. Cochrane Database Syst Rev (2007) 2.08
Delivery of therapeutic agents to the central nervous system: the problems and the possibilities. Pharmacol Ther (2004) 1.96
The efficiency of simulation-based multiple comparisons. Biometrics (1987) 1.91
Cognitive and functional outcome after aneurysmal subarachnoid hemorrhage. Stroke (2010) 1.78
Approaches to transport therapeutic drugs across the blood-brain barrier to treat brain diseases. Neurobiol Dis (2009) 1.70
Delayed neurological deterioration after subarachnoid haemorrhage. Nat Rev Neurol (2013) 1.64
Effect of pharmaceutical treatment on vasospasm, delayed cerebral ischemia, and clinical outcome in patients with aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis. J Cereb Blood Flow Metab (2011) 1.58
Application of nicardipine prolonged-release implants: analysis of 97 consecutive patients with acute subarachnoid hemorrhage. Neurosurgery (2005) 1.56
The efficacy of an abbreviated course of nimodipine in patients with good-grade aneurysmal subarachnoid hemorrhage. J Neurosurg (1999) 1.42
Nimodipine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in cerebrovascular disease. Drugs (1989) 1.25
The vascular neural network--a new paradigm in stroke pathophysiology. Nat Rev Neurol (2012) 1.23
Evidence-based cerebral vasospasm management. Neurosurg Focus (2006) 1.09
The effects of nimodipine, its optical isomers and metabolites on isolated vascular smooth muscle. Arzneimittelforschung (1982) 1.06
Dissociation of vasospasm and secondary effects of experimental subarachnoid hemorrhage by clazosentan. Stroke (2011) 0.96
Role of p53 and apoptosis in cerebral vasospasm after experimental subarachnoid hemorrhage. J Cereb Blood Flow Metab (2005) 0.94
Ischemia triggered by red blood cell products in the subarachnoid space is inhibited by nimodipine administration or moderate volume expansion/hemodilution in rats. Neurosurgery (2002) 0.92
Drug delivery into the brain using poly(lactide-co-glycolide) microspheres. Expert Opin Drug Deliv (2005) 0.88
Vasospasm after aneurysmal subarachnoid hemorrhage: recent advances in endovascular management. Curr Opin Crit Care (2010) 0.86
Dihydropyridine calcium antagonists increase fibrinolytic activity: a systematic review. J Cereb Blood Flow Metab (2006) 0.86
Reversal of cerebral vasospasm by sphenopalatine ganglion stimulation in a dog model of subarachnoid hemorrhage. Surg Neurol (2005) 0.86
Treatment of cerebral vasospasm with biocompatible controlled-release systems for intracranial drug delivery. Neurosurgery (2008) 0.81
In situ forming nimodipine depot system based on microparticles for the treatment of posthemorrhagic cerebral vasospasm. Eur J Pharm Biopharm (2013) 0.80